Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11621)
All Articles published online
|
Publishing Process of This Article
|
Dec 16, 2013 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Crumley SM, Divatia M, Truong L, Shen S, Ayala AG, Ro JY. Renal cell carcinoma: Evolving and emerging subtypes. World J Clin Cases 2013; 1(9): 262-275 [PMID: 24364021 DOI: 10.12998/wjcc.v1.i9.262] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v1/i9/262.htm |
| Number | Citing Articles |
| 1 |
Liu Qin, Yanhong Liu, Menglong Li, Xuemei Pu, Yanzhi Guo. The landscape of miRNA-related ceRNA networks for marking different renal cell carcinoma subtypes. Briefings in Bioinformatics 2018; doi: 10.1093/bib/bby101
|
| 2 |
Yongquan Wang, Peng He, Xiaozhou Zhou, Cong Wang, Jian Fu, Dawei Zhang, Deyang Liao, Zhansong Zhou, Chunman Wu, Wei Gong. Gene mutation profiling and clinical significances in patients with renal cell carcinoma. Clinics 2023; 78: 100259 doi: 10.1016/j.clinsp.2023.100259
|
| 3 |
Omar Abdel-Rahman, Mona Fouad. Efficacy and toxicity of sunitinib for non clear cell renal cell carcinoma (RCC): A systematic review of the literature. Critical Reviews in Oncology/Hematology 2015; 94(2): 238 doi: 10.1016/j.critrevonc.2015.01.006
|
| 4 |
Sanghui Park, Jae Y. Ro. Renal Cell Neoplasms: Recent Advances. The Ewha Medical Journal 2014; 37(1): 16 doi: 10.12771/emj.2014.37.1.16
|
| 5 |
Joseph Milo Hibbert, Karmon Janssen, Novae B. Simper. Renal Cell Carcinoma With (Angio)Leiomyomatous Stroma in a Patient With TSC2 Mutation: A Case Report. AJSP: Reviews and Reports 2018; 23(6): 284 doi: 10.1097/PCR.0000000000000274
|
| 6 |
Dana V. Rizk, Bharathi Reddy, Arlene B. Chapman. National Kidney Foundation' s Primer on Kidney Diseases. 2018; : 375 doi: 10.1016/B978-0-323-47794-9.00040-8
|
| 7 |
Narayan Acharya, Kamaleshwar P. Singh. Recent advances in the molecular basis of chemotherapy resistance and potential application of epigenetic therapeutics in chemorefractory renal cell carcinoma. WIREs Mechanisms of Disease 2022; 14(6) doi: 10.1002/wsbm.1575
|
| 8 |
Alejandro Rubio Fernández, Mario Díaz Delgado, Alicia Hernández Amate. Múltiples hemangiomas anastomosantes y lesiones precursoras de carcinoma de células renales asociado a enfermedad renal quística adquirida. Revista Española de Patología 2015; 48(2): 103 doi: 10.1016/j.patol.2014.09.005
|
| 9 |
Dahai Zhou, Vinodh Kannappan, Xiang Chen, Jingqin Li, Xuefeng Leng, Jinping Zhang, Shiying Xuan. RBP2 induces stem-like cancer cells by promoting EMT and is a prognostic marker for renal cell carcinoma. Experimental & Molecular Medicine 2016; 48(6): e238 doi: 10.1038/emm.2016.37
|
| 10 |
Narayan Acharya, Kamaleshwar P. Singh. Differential sensitivity of renal carcinoma cells to doxorubicin and epigenetic therapeutics depends on the genetic background. Molecular and Cellular Biochemistry 2021; 476(6): 2365 doi: 10.1007/s11010-021-04076-7
|
| 11 |
Anne Offermann, Christiane Kuempers, Sven Perner. Urologic Oncology. 2019; : 537 doi: 10.1007/978-3-319-42623-5_60
|
| 12 |
Klaudia K. Brodaczewska, Cezary Szczylik, Michal Fiedorowicz, Camillo Porta, Anna M. Czarnecka. Choosing the right cell line for renal cell cancer research. Molecular Cancer 2016; 15(1) doi: 10.1186/s12943-016-0565-8
|
| 13 |
Anitha B Chalageri, K G Arun, T P Dinesh Kumar, G B Vijaykumar. Acquired Cystic Kidney Disease Associated Renal Cell Carcinoma: A Case Report. Journal of Medical Sciences and Health 2015; 1(02): 39 doi: 10.46347/JMSH.2015.v01i02.009
|
| 14 |
Michelle S. Hirsch, Sabina Signoretti, Paola Dal Cin. Adult Renal Cell Carcinoma. Surgical Pathology Clinics 2015; 8(4): 587 doi: 10.1016/j.path.2015.09.003
|
| 15 |
S. Karami, E.L. Yanik, L.E. Moore, R.M. Pfeiffer, G. Copeland, L. Gonsalves, B.Y. Hernandez, C.F. Lynch, K. Pawlish, E.A. Engels. Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States. American Journal of Transplantation 2016; 16(12): 3479 doi: 10.1111/ajt.13862
|
| 16 |
Leili Mirsadraei, Michelle S. Hirsch, Christopher J. Kane, Donna E. Hansel. The Kidney. 2016; : 125 doi: 10.1007/978-1-4939-3286-3_9
|
| 17 |
Fengju Chen, Yiqun Zhang, Yasin Şenbabaoğlu, Giovanni Ciriello, Lixing Yang, Ed Reznik, Brian Shuch, Goran Micevic, Guillermo De Velasco, Eve Shinbrot, Michael S. Noble, Yiling Lu, Kyle R. Covington, Liu Xi, Jennifer A. Drummond, Donna Muzny, Hyojin Kang, Junehawk Lee, Pheroze Tamboli, Victor Reuter, Carl Simon Shelley, Benny A. Kaipparettu, Donald P. Bottaro, Andrew K. Godwin, Richard A. Gibbs, Gad Getz, Raju Kucherlapati, Peter J. Park, Chris Sander, Elizabeth P. Henske, Jane H. Zhou, David J. Kwiatkowski, Thai H. Ho, Toni K. Choueiri, James J. Hsieh, Rehan Akbani, Gordon B. Mills, A. Ari Hakimi, David A. Wheeler, Chad J. Creighton. Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Reports 2016; 14(10): 2476 doi: 10.1016/j.celrep.2016.02.024
|
| 18 |
Taylor M. Jenkins, Jason Rosenbaum, Paul J. Zhang, Lauren E. Schwartz, Anupma Nayak, Kumarasen Cooper, Satish K. Tickoo, Priti Lal. Thyroid-Like Follicular Carcinoma of the Kidney With Extensive Sarcomatoid Differentiation: A Case Report and Review of the Literature. International Journal of Surgical Pathology 2019; 27(6): 678 doi: 10.1177/1066896919845490
|
| 19 |
|
| 20 |
Jacek Rysz, Beata Franczyk, Janusz Ławiński, Anna Gluba-Brzózka. Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC). International Journal of Molecular Sciences 2021; 23(1): 151 doi: 10.3390/ijms23010151
|
| 21 |
Mihyang Ha, Hoim Jeong, Jong Seong Roh, Beomgu Lee, Myoung-Eun Han, Sae-Ock Oh, Dong Hyun Sohn, Yun Hak Kim. DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts. Urologic Oncology: Seminars and Original Investigations 2019; 37(10): 735 doi: 10.1016/j.urolonc.2019.07.007
|
| 22 |
Kevin G. King, Mittul Gulati, Harshawn Malhi, Darryl Hwang, Inderbir S. Gill, Phillip M. Cheng, Edward G. Grant, Vinay A. Duddalwar. Quantitative assessment of solid renal masses by contrast-enhanced ultrasound with time–intensity curves: how we do it. Abdominal Imaging 2015; 40(7): 2461 doi: 10.1007/s00261-015-0468-y
|
| 23 |
Anne Offermann, Christiane Kuempers, Sven Perner. Urologic Oncology. 2017; : 1 doi: 10.1007/978-3-319-42603-7_60-1
|
| 24 |
Dimo Dietrich, Sebastian Meller, Barbara Uhl, Bernhard Ralla, Carsten Stephan, Klaus Jung, Jörg Ellinger, Glen Kristiansen. Nucleic acid-based tissue biomarkers of urologic malignancies. Critical Reviews in Clinical Laboratory Sciences 2014; 51(4): 173 doi: 10.3109/10408363.2014.906130
|
| 25 |
Jie Hu, Yujin Zong, Jun Li, Xiaodong Zhou, Jun Zhang, Ting Zhu, Mingke Jiao, Haili Su, Bin Bo. In Vitro and In Vivo Evaluation of Targeted Sunitinib‐Loaded Polymer Microbubbles Against Proliferation of Renal Cell Carcinoma. Journal of Ultrasound in Medicine 2016; 35(3): 589 doi: 10.7863/ultra.14.10038
|